Deadline Approaching for Elanco Animal Advised by Berger Montague
Investors, listen up! There’s a securities class action lawsuit happening with Elanco Animal Health Inc. (“Elanco” or the “Company”) (NYSE: ELAN) that you need to know about. If you bought Elanco securities between November 7, 2023, and June 26, 2024, you might be eligible to be a lead plaintiff representative. The deadline to take action is coming up on December 6, 2024, so don’t miss out.
Elanco is all about animal health, focusing on products for pets and farm animals. They’ve got things like Zenrelia, which helps with canine dermatology, and Credelio Quattro, a parasiticide for dogs. But here’s the thing: there’s a lawsuit claiming that Elanco didn’t quite deliver on what they promised. Allegedly, there were some safety concerns with Zenrelia, and Elanco wasn’t on track to get FDA approval for their products as planned.
When the news broke on June 27, 2024, about potential delays and safety issues, Elanco’s stock took a hit, dropping 20%. If you want to learn more about the lawsuit and possibly become a lead plaintiff, now’s the time to act. Being a lead plaintiff means you get to represent all the investors in the case, and you could be a key player in getting justice. Don’t worry; you can still get a piece of any recovery without being a lead plaintiff if you choose.
If you’re interested in participating or learning more, reach out to Berger Montague, a seasoned player in securities class action cases, with a track record dating back to 1970. You can contact Andrew Abramowitz at aabramowitz@bm.net or (215) 875-3015, or Peter Hamner at phamner@bm.net or (215) 875-3048. Get the details and see if you want to get involved in this important case.
